In which clinical situations (acute or persistent diarrhea, chronic diarrhea, bloody stool, iron‑deficiency anemia, colorectal cancer screening, malabsorption, immunosuppression, recent antibiotic use, recent travel, or infants/young children) should stool testing be ordered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Order Stool Testing: Clinical Indications

Order stool testing in patients with chronic diarrhea (>4 weeks) after initial screening blood tests, in acute diarrhea with fever/bloody stools/severe symptoms, in immunocompromised patients, and when specific risk factors for infection or inflammation are present. 1, 2

Initial Screening Approach for Chronic Diarrhea

All patients with chronic diarrhea require basic stool testing alongside blood work as part of the initial diagnostic workup. 1

  • Perform stool tests for inflammation (fecal calprotectin) and infection screening in all chronic diarrhea cases before making a diagnosis of IBS 1
  • Blood tests (CBC, ESR, CRP, celiac serology, thyroid function) should be done concurrently with stool studies 1
  • Fecal calprotectin is specifically recommended to exclude colonic inflammation in patients under age 40 suspected of having IBS 1

Acute Diarrhea: When Stool Testing is Mandatory

Order stool cultures and testing immediately when acute diarrhea presents with any of these features: 2

  • Fever accompanying diarrhea 2
  • Bloody or mucoid stools 2
  • Severe abdominal cramping or tenderness 2
  • Signs of sepsis 2
  • Severe dehydration 3

For these presentations, test specifically for Salmonella, Shigella, Campylobacter, Yersinia, C. difficile, and Shiga toxin-producing E. coli (STEC) 2. A single diarrheal stool specimen is optimal for diagnosis 2.

Do not routinely order stool tests in self-limiting acute diarrhea without these features. 3

Special Population Requirements

Immunocompromised Patients

Perform broad stool testing including culture, viral studies, and parasite examination in all immunocompromised patients with diarrhea. 2

  • For AIDS patients with persistent diarrhea, add testing for Cryptosporidium, Cyclospora, Cystoisospora, Microsporidia, Mycobacterium avium complex, and Cytomegalovirus 2
  • Blood cultures are mandatory in immunocompromised patients when infection is suspected 2

Recent Antibiotic Use

Test for C. difficile toxin in any patient with diarrhea following recent antibiotic exposure. 2, 4

Recent Travel to Endemic Areas

Order stool ova and parasite (O&P) examination in patients with: 5

  • Travel to endemic areas within the past several weeks 5
  • Diarrhea lasting >7 days 5
  • Additional risk factors: smoking, prior parasitic disease, HIV-positive status, or institutionalization 5

Avoid routine inpatient O&P testing in patients without these specific risk factors, as the yield is only 2.15%. 5

Infants and Young Children

Order stool cultures including Yersinia testing in infants and young children with: 2

  • Exposure to raw or undercooked pork products 2
  • Right lower quadrant abdominal pain mimicking appendicitis 2
  • Fever with epidemiologic risk factors 2

Blood cultures are mandatory in all infants <3 months with suspected gastrointestinal infection 2.

Specific Clinical Scenarios Requiring Stool Testing

Bloody Stool or Iron-Deficiency Anemia

Order fecal immunochemical testing (FIT) in patients with altered bowel habit without visible rectal bleeding to guide investigation priority. 1

  • Colonoscopy with biopsies takes precedence over stool testing when colorectal cancer or inflammation is suspected 1
  • Test stool for Salmonella, Shigella, Campylobacter, Yersinia, and STEC in bloody diarrhea 2

Suspected Malabsorption

Order stool elastase testing when fat malabsorption is suspected. 1

  • Stool studies help categorize diarrhea as watery, fatty, or inflammatory when the differential diagnosis is broad 6, 7
  • Consider stool testing for Giardia in suspected malabsorptive diarrhea with weight loss 4

Persistent Symptoms Despite Normal Initial Workup

Repeat stool tests for malabsorption and infections (especially in elderly or immunocompromised) when symptoms persist after negative first-line investigations. 1

Suspected Microscopic Colitis

Colonoscopy with biopsies (not stool testing alone) is required to diagnose microscopic colitis. 1

However, fecal calprotectin may be elevated and can prompt this investigation 1.

Key Testing Pitfalls to Avoid

  • Do not order routine stool cultures in immunocompetent patients with chronic diarrhea (>4 weeks), as infectious causes are uncommon. 1 Focus instead on inflammatory markers and malabsorption studies 1
  • Explicitly request Yersinia testing on stool culture orders, as it is not included in standard bacterial panels. 2
  • Do not rely solely on multiplex molecular tests without clinical context, as they detect DNA rather than viable organisms. 2
  • Perform laxative screening early in specialist referral practice for chronic diarrhea, as factitious diarrhea becomes increasingly common. 1

Age-Based Considerations

In patients under 45 years with typical IBS symptoms and negative screening tests (including stool calprotectin), a diagnosis can be made without further stool testing. 1

Patients under 45 with atypical or severe symptoms and documented diarrhea require stool testing and further evaluation. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approaches for Gastrointestinal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diarrhea as a Clinical Challenge: General Practitioner Approach.

Digestive diseases (Basel, Switzerland), 2022

Research

Evaluation of chronic diarrhea.

American family physician, 2011

Research

An audit of inpatient stool ova and parasite (O&P) testing in a multi-hospital health system.

Journal of community hospital internal medicine perspectives, 2020

Research

Screening for gastrointestinal and pancreatic diseases.

Advances in clinical chemistry, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.